本季度信息
康龙化成(股票代码：03759)公布截至2026年3月31日止第一季度业绩，营业收入约35.78亿元，同比增长15.48%。经调整净利润约4.06亿元，同比增长16.25%。报告期内经营活动产生的现金流量净额约6.04亿元，同比下降29.13%。 从成本结构看，销售费用增长至约0.78亿元，同比增长约13%，管理费用约4.42亿元，同比增长约11%，公司研发投入约1.40亿元，占收入比仍保持在较高水平，同比增长约14%。
业务分项
按照业务板块划分，实验室服务实现收入21.22亿元，同比增长14.27%，毛利率从上年同期的45.54%微降至44.11%；CMC（小分子CDMO）服务收入8.66亿元，同比增长25.01%，毛利率提升至31.45%；临床研究服务收入5.00亿元，同比增长11.80%，毛利率为7.10%；大分子和细胞与基因治疗服务实现收入0.88亿元，同比下降11.00%，板块毛利率为-92.80%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.